Peer-reviewed, open access journal

Menu

Cancer Immunology & Translational Research

  • Cancer Immunology & Translational Research
  • Connecting advances in cancer immunology with translational opportunities in oncology

Cancer Immunology & Translational Research (CITR) is an international, peer-reviewed, open-access journal dedicated to advancing scientific understanding of the interactions between cancer and the immune system and translating emerging discoveries toward clinically meaningful applications.

CITR welcomes rigorous research spanning fundamental cancer immunology, tumor–immune interactions, immunotherapeutic approaches, tumor microenvironment, biomarker discovery, immune profiling, therapeutic resistance, precision oncology, and translational cancer research.

The journal encourages multidisciplinary research that strengthens the connection between mechanistic insight, experimental validation, translational development, and clinical relevance.

Research Across the Translational Spectrum

Cancer Biology → Immune Mechanisms → Translational Discovery → Therapeutic Development → Clinical Investigation

Featured Sections

Explore the ScienceDiscover research addressing emerging questions in cancer immunology and translational oncology.

Submit Your ResearchAuthors are invited to contribute scientifically rigorous research aligned with the journal's scope.

Explore the JournalLearn about the journal's editorial policies, peer-review standards, publication ethics, and open-access model.

Current issue articles will appear here.

Accepted articles will appear here before issue assignment.